ExThera Medical was established in 2007 by the Emergence Venture Partners life science incubator and ExThera AB at Karolinska Institute in Stockholm. We focus on the treatment of drug-resistant and drug-sensitive blood infections in high-risk patient populations, and provide field-deployable versions for the biological defense and military fields. Our headquarters is in Martinez, California.
The company’s first product, Seraph 100 Microbind Affinity Blood Filter, has received CE- certification in 2019, for the reduction of pathogens during bloodstream infection in adjunction to antibiotic therapy, and is commercially available in Europe.